- Clinical Trials
- January 2024
- 100 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
- Report
- November 2021
- 844 Pages
Global
From €4772EUR$5,000USD£3,998GBP
Ifenprodil is a drug used to treat central nervous system (CNS) disorders. It is a selective antagonist of the NMDA receptor, which is involved in the regulation of neuronal excitability. Ifenprodil is used to treat a variety of CNS disorders, including schizophrenia, bipolar disorder, and depression. It is also used to treat anxiety and insomnia. The drug is available in both oral and injectable forms.
Ifenprodil is a relatively new drug, and its use is still being studied. It is believed to have fewer side effects than other CNS drugs, and it is thought to be more effective in treating certain conditions.
The Ifenprodil market is growing as more people are turning to this drug to treat their CNS disorders. Companies such as Sun Pharmaceuticals, Lupin Pharmaceuticals, and Dr. Reddy's Laboratories are leading the way in the Ifenprodil market. Other companies such as Cipla, Intas Pharmaceuticals, and Glenmark Pharmaceuticals are also involved in the market. Show Less Read more